Published in Oncology on January 01, 1989
The Ras-association domain family (RASSF) members and their role in human tumourigenesis. Biochim Biophys Acta (2007) 2.82
Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma. PLoS Negl Trop Dis (2009) 1.63
Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA. Genome Res (2007) 1.62
Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer. J Mol Diagn (2004) 1.62
Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer. Nat Rev Cancer (2010) 1.51
Influence of neuroblastoma stage on serum-based detection of MYCN amplification. Pediatr Blood Cancer (2009) 1.49
Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. Proc Natl Acad Sci U S A (2014) 1.46
Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. Br J Cancer (1997) 1.45
Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer (2005) 1.40
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease. EMBO Mol Med (2015) 1.37
Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched. RNA (2008) 1.35
Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res (2010) 1.28
Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer. Int J Cancer (2013) 1.27
Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers. Br J Cancer (2007) 1.22
Genomic targets in saliva. Ann N Y Acad Sci (2007) 1.16
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours. Hugo J (2011) 1.13
Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World J Gastroenterol (2008) 1.08
Association between lifestyle factors and CpG island methylation in a cancer-free population. Cancer Epidemiol Biomarkers Prev (2009) 1.07
Circulating tumor cells and DNA as liquid biopsies. Genome Med (2013) 1.06
Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers. World J Surg (2004) 1.05
Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. Br J Cancer (1999) 1.03
Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades. Neuro Oncol (2010) 1.01
Prognostic Impact of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Treated using Intensity-Modulated Radiation Therapy. Sci Rep (2016) 0.98
Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load. Transl Oncol (2013) 0.95
Circulating nucleic acids as biomarkers in breast cancer. Breast Cancer Res (2013) 0.94
Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol (2017) 0.94
Identification of mouse serum miRNA endogenous references by global gene expression profiles. PLoS One (2012) 0.93
Non-invasive Prenatal Testing: Technologies, Clinical Assays and Implementation Strategies for Women's Healthcare Practitioners. Curr Genet Med Rep (2013) 0.93
Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology. Onco Targets Ther (2013) 0.92
The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol (2006) 0.92
LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival. BMC Cancer (2012) 0.91
Cancer progression mediated by horizontal gene transfer in an in vivo model. PLoS One (2012) 0.91
High-Mobility Group A (HMGA) Proteins and Breast Cancer. Breast Care (Basel) (2010) 0.89
Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer (2017) 0.88
Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev (2016) 0.87
Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance. Genome Biol (2014) 0.86
Hypermethylation of p16INK4a in Korean non-small cell lung cancer patients. J Korean Med Sci (2007) 0.86
Presence of mitochondrial tRNA(Leu(UUR)) A to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus. J Clin Pathol (2000) 0.85
Cell-free circulating tumor DNA in cancer. Chin J Cancer (2016) 0.85
Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis. Breast Cancer Res (2012) 0.84
The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy. Br J Cancer (2011) 0.84
Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer. Clin Transl Sci (2012) 0.84
Circulating tumor DNA moves further into the spotlight. Genome Med (2014) 0.83
Circulating nucleic acids in plasma and serum: diagnosis and prognosis in cancer. EPMA J (2010) 0.81
Microsatellite abnormalities in plasma of patients with breast carcinoma: concordance with the primary tumour. J Clin Pathol (1999) 0.81
Circulating and stool nucleic acid analysis for colorectal cancer diagnosis. World J Gastroenterol (2014) 0.81
Serum messenger RNA as a biomarker and its clinical usefulness in malignancies. Clin Med Oncol (2008) 0.80
Mutations of p53 gene can be detected in the plasma of patients with large bowel carcinoma. J Clin Pathol (1998) 0.80
Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients. World J Gastroenterol (2006) 0.79
Plasma DNA restoration for PCR applications. J Clin Pathol (2007) 0.78
Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions. Cell Mol Gastroenterol Hepatol (2017) 0.77
Free DNA--new potential analyte in clinical laboratory diagnostics? Biochem Med (Zagreb) (2012) 0.77
Circulating nucleic acids in plasma and serum: applications in diagnostic techniques for noninvasive prenatal diagnosis. Int J Womens Health (2013) 0.76
The liquid biopsy in lung cancer. Genes Cancer (2016) 0.76
Cell-free DNA as a diagnostic marker for cancer: current insights. Onco Targets Ther (2016) 0.75
Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth. Mol Ther (2015) 0.75
Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer. World J Gastroenterol (2016) 0.75
Circulating tumor DNA in hepatocellular carcinoma: trends and challenges. Cell Biosci (2016) 0.75
Emerging concepts in liquid biopsies. BMC Med (2017) 0.75
Circulating tumor DNA: a resuscitative gold mine? Ann Transl Med (2015) 0.75
Circulating nucleic acids: An analysis of their occurrence in malignancies. Biomed Rep (2016) 0.75
Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment. PLoS One (2017) 0.75
Circulating Tumor DNA as Biomarkers for Cancer Detection. Genomics Proteomics Bioinformatics (2017) 0.75
Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer. Oncol Lett (2017) 0.75
Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients. Oncotarget (2017) 0.75
Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med (1996) 2.95
Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med (1996) 2.85
About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta (2001) 2.18
The origin and mechanism of circulating DNA. Ann N Y Acad Sci (2000) 1.87
The surgical treatment of constrictive fibrous endocarditis. Ann Surg (1976) 1.81
Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol (1994) 1.55
Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res (2000) 1.54
Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system. Cancer Res (1975) 1.51
Firearms injury prevention and gun control in Canada. CMAJ (1996) 1.46
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br J Pharmacol (2008) 1.42
Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol (1987) 1.37
A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. Clin Cancer Res (1998) 1.36
Surgical treatment of constrictive fibrous endocarditis. J Thorac Cardiovasc Surg (1981) 1.32
K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology (1997) 1.29
Agrobacterium tumefaciens ribonucleic acid synthesis in tomato cells and crown gall induction. J Bacteriol (1971) 1.19
Bacterial nucleic acid synthesis in plants following bacterial contact. Mol Gen Genet (1971) 1.18
Natural release of nucleic acids from bacteria into plant cells. Nature (1970) 1.16
Alu repeat sequences are present in increased proportions compared to a unique gene in plasma/serum DNA: evidence for a preferential release from viable cells? Ann N Y Acad Sci (2001) 1.15
Self-injurious behavior prevalence and relationships to environmental events. Monogr Am Assoc Ment Defic (1982) 1.14
Non-invasive diagnosis of mitral regurgitation by Doppler echocardiography. Br Heart J (1981) 1.14
Circulating nucleic acids in plasma or serum. Clin Chim Acta (2001) 1.13
DNA replication in Solanum lycopersicum esc. after absorption of bacterial DNA. Curr Mod Biol (1967) 1.11
Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res (1999) 1.07
Bacterial RNA synthesis in animal cells following bacterial contact. FEBS Lett (1971) 1.07
Non-invasive quantification of aortic regurgitation by Doppler echocardiography. Br Heart J (1983) 1.07
Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. Cancer Res (1998) 1.06
Pulsed doppler echocardiographic study of mitral stenosis. Circulation (1980) 1.05
Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: follow-up study and prognostic significance. Ann Oncol (2000) 1.04
[Hockey injuries: consultations in a hospital center in Quebec]. Can J Public Health (1996) 0.98
Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture. Cancer Res (1978) 0.97
Drastic alteration of ribosomal RNA and ribosomal proteins in showdomycin-resistant Escherichia coli. Proc Natl Acad Sci U S A (1971) 0.95
Combined chemo- and hormonal therapy in advanced breast cancer. Cancer (1977) 0.93
Nucleic acids spontaneously released by living frog auricles. Biochem J (1972) 0.92
Circulating nucleic acids in higher organisms. Int Rev Cytol (1977) 0.92
[Hemodynamic effects of intravenous injections of amiodarone chlorhydrate in normal subjects and coronary patients]. Arch Mal Coeur Vaiss (1976) 0.91
Translocation of DNA of bacterial origin in Lycopersicum esculentum by ultracentrifugation in caesium chloride gradient. Nature (1967) 0.91
[Disorders of rhythm and auriculo-ventricular conduction in recent myocardial infarct. Anatomical considerations]. Arch Mal Coeur Vaiss (1967) 0.91
Plasma DNA K-ras mutations in patients with gastrointestinal malignancies. Ann N Y Acad Sci (2000) 0.90
The use of genetic instability as a clinical tool for cancer diagnosis. Semin Cancer Biol (1998) 0.89
[Synthesis in Escherichia coli of RNA whose primary structure differs entirely from that of DNA]. C R Acad Sci Hebd Seances Acad Sci D (1968) 0.89
Transformation of Agrobacterium tumefaciens into a non-oncogenic species by an Escherichia coli RNA. Proc Natl Acad Sci U S A (1972) 0.89
[Anatomical study of rheumatic tricuspid valve diseases: Application to the study of various valvuloplasties]. Ann Chir Thorac Cardiovasc (1973) 0.88
[Showdomycin and biosynthesis of RNA non complementary to DNA. I]. Ann Inst Pasteur (Paris) (1970) 0.88
Isolation of the tumor-inducing RNA from oncogenic and nononcogenic Agrobacterium tumefaciens. Proc Natl Acad Sci U S A (1974) 0.88
The role of extracellular DNA in the transfer of information from T to B human lymphocytes in the course of an immune response. J Immunogenet (1980) 0.88
[Transcription by polynucleotide phosphorylase of DNA-associated RNA of Escherichia coli]. C R Acad Sci Hebd Seances Acad Sci D (1971) 0.86
Neutral carrier based ion-selective electrode for the determination of total calcium in blood serum. Anal Chem (1981) 0.86
[Hisian tachycardia in an adult with corrected transposition of great vessels]. Arch Mal Coeur Vaiss (1979) 0.86
Solitary iris nevus associated with peripheral anterior synechiae and iris endothelialization. Am J Ophthalmol (1977) 0.85
[Some special aspects of obstructive cardiomyopathy in patients over 55 years of age (apropos of 14 cases)]. Arch Mal Coeur Vaiss (1970) 0.85
Quantitative assessment of tricuspid regurgitation using pulsed Doppler echocardiography. Br Heart J (1983) 0.85
[Endomyocardial fibrosis during filariasis. Apropos of a surgically treated case]. Ann Med Interne (Paris) (1974) 0.85
[Transforming RNA bearers of hereditary characters in showdomycino-resistant Escherichia coli]. C R Acad Sci Hebd Seances Acad Sci D (1971) 0.84
Potentiometry of Na+ in undiluted serum and urine with use of an improved neutral carrier-based solvent polymeric membrane electrode. Clin Chem (1983) 0.84
Bacterial ribonucleic acid in the frog brain after a bacterial peritoneal infection. Science (1972) 0.84
Spontaneous extracellular synthesis of DNA released by human blood lymphocytes. Cancer Res (1976) 0.84
[RNA episome carried by the DNA of wild and showdomycin-resistant Escherichia coli]. C R Acad Sci Hebd Seances Acad Sci D (1971) 0.84
Acute myelogenous leukaemia: maintenance chemotherapy after early consolidation treatment does not prolong survival. Lancet (1984) 0.84
[Transformation of NIH/3T3 cells and SW 480 cells displaying K-ras mutation]. C R Acad Sci III (1994) 0.84
Metabolic DNA in heart and skeletal muscle and in the intestine of mice. Nature (1967) 0.83
In vitro synthesis of DNA spontaneously released by bacteria or frog auricles. Biochimie (1972) 0.82
Bacterial nature of radioactive DNA found in tomato plants incubated in the presence of bacterial DNA-3H. Nature (1968) 0.82
Circulating DNA in higher organisms cancer detection brings back to life an ignored phenomenon. Cell Mol Biol (Noisy-le-grand) (2005) 0.82
[Severe postoperative heart blocks appearing late. 16 cases]. Arch Mal Coeur Vaiss (1983) 0.82
[Abnormal cardiac silhouette and thymic tumors (11 cases)]. J Radiol Electrol Med Nucl (1970) 0.81
[RNA isolated from turnip yellow mosaic virus; acceptor of amino acids in the presence of bacterial enzymes]. Bull Soc Chim Biol (Paris) (1965) 0.81
About safety and safety promotion concepts. Inj Prev (2004) 0.80
Information carried by the DNA released by antigen-stimulated lymphocytes. Immunology (1979) 0.80